| Uganda’s experience in Ebola virus disease outbreak preparedness, 2018–2019 JR Aceng, AR Ario, AN Muruta, I Makumbi, M Nanyunja, I Komakech, ... Globalization and Health 16, 1-12, 2020 | 98 | 2020 |
| Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within … NI Paton, C Kityo, J Thompson, I Nankya, L Bagenda, A Hoppe, J Hakim, ... The lancet HIV 4 (8), e341-e348, 2017 | 84 | 2017 |
| Marburg virus disease outbreak in Kween District Uganda, 2017: Epidemiological and laboratory findings L Nyakarahuka, TR Shoemaker, S Balinandi, G Chemos, B Kwesiga, ... PLoS neglected tropical diseases 13 (3), e0007257, 2019 | 77 | 2019 |
| Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed‐Method Study TS Boender, KCE Sigaloff, J Kayiwa, V Musiime, JCJ Calis, RL Hamers, ... AIDS research and treatment 2012 (1), 817506, 2012 | 61 | 2012 |
| Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up … JG Hakim, J Thompson, C Kityo, A Hoppe, A Kambugu, JJ van Oosterhout, ... The Lancet Infectious Diseases 18 (1), 47-57, 2018 | 52 | 2018 |
| Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children V Musiime, E Kaudha, J Kayiwa, G Mirembe, M Odera, H Kizito, I Nankya, ... AIDS research and human retroviruses 29 (3), 449-455, 2013 | 51 | 2013 |
| HIV drug resistance among children initiating first-line antiretroviral treatment in Uganda C Kityo, KCE Sigaloff, TS Boender, E Kaudha, J Kayiwa, V Musiime, ... AIDS research and human retroviruses 32 (7), 628-635, 2016 | 44 | 2016 |
| Improving adherence to antiretroviral treatment in Uganda with a low-resource facility-based intervention C Obua, J Kayiwa, P Waako, G Tomson, H Balidawa, J Chalker, ... Global health action 7 (1), 24198, 2014 | 38 | 2014 |
| Notes from the field: outbreak of Ebola virus disease caused by Sudan ebolavirus—Uganda, August–October 2022 T Kiggundu MMWR. Morbidity and Mortality Weekly Report 71, 2022 | 31 | 2022 |
| high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy KCE Sigaloff, J Kayiwa, V Musiime, JCJ Calis, E Kaudha, A Mukuye, ... AIDS research and human retroviruses 29 (6), 925-930, 2013 | 26 | 2013 |
| Effect of the good school toolkit on school staff mental health, sense of job satisfaction and perceptions of school climate: Secondary analysis of a cluster randomised trial J Kayiwa, K Clarke, L Knight, E Allen, E Walakira, S Namy, KG Merrill, ... Preventive medicine 101, 84-90, 2017 | 24 | 2017 |
| Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine V Musiime, F Ssali, J Kayiwa, W Namala, H Kizito, C Kityo, P Mugyenyi AIDS research and human retroviruses 25 (10), 989-996, 2009 | 24 | 2009 |
| HIV type 1 disease progression to AIDS and death in a rural Ugandan cohort is primarily dependent on viral load despite variable subtype and T-cell immune activation levels MA Eller, MS Opollo, M Liu, AD Redd, LA Eller, C Kityo, J Kayiwa, ... The Journal of infectious diseases 211 (10), 1574-1584, 2015 | 23 | 2015 |
| Prevalence, factors associated and treatment outcome of hyperbilirubinaemia in neonates admitted to St Francis hospital, Nsambya, Uganda: a descriptive study C Nyangabyaki-Twesigye, E Mworozi, C Namisi, V Nakibuuka, J Kayiwa, ... African health sciences 20 (1), 397-405, 2020 | 21 | 2020 |
| The logic model for Uganda’s health sector preparedness for public health threats and emergencies AR Ario, I Makumbi, L Bulage, S Kyazze, J Kayiwa, MM Wetaka, ... Global health action 12 (1), 1664103, 2019 | 21 | 2019 |
| Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial V Musiime, A Cook, J Kayiwa, D Zangata, C Nansubuga, B Arach, ... Antiviral therapy 19 (3), 269-276, 2014 | 20 | 2014 |
| Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda V Musiime, J Kayiwa, M Kiconco, W Tamale, H Alima, H Mugerwa, ... AIDS research and human retroviruses 28 (12), 1647-1657, 2012 | 20 | 2012 |
| Second-line HIV treatment in Ugandan children: favorable outcomes and no protease inhibitor resistance RS Boerma, C Kityo, TS Boender, E Kaudha, J Kayiwa, V Musiime, ... Journal of tropical pediatrics 63 (2), 135-143, 2017 | 19 | 2017 |
| Healthworker preparedness for COVID-19 management and implementation experiences: a mixed methods study in Uganda’s refugee-hosting districts G Seruwagi, C Nakidde, F Otieno, J Kayiwa, B Luswata, E Lugada, ... Conflict and Health 15, 1-22, 2021 | 17 | 2021 |
| Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography technique M Lamorde, Q Fillekes, K Sigaloff, C Kityo, A Buzibye, J Kayiwa, C Merry, ... BMC Infectious Diseases 14, 1-6, 2014 | 16 | 2014 |
